Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-6
客服专线︰ +852 3018 4526
交易日︰全日24小时 | 非交易日：9:00-18:00
